AM, H., M, A., MM, M., E, A., SS, S., MA, S., . . . MF, M. (2025). Efficacy and safety of nitazoxanide based quadruple regimen as first line therapy for treating Helicobacter pylori infected naïve patients. Journal of infection in developing countries, 19(6), 843. https://doi.org/10.3855/jidc.20505
Chicago Style (17th ed.) CitationAM, Hassan, et al. "Efficacy and Safety of Nitazoxanide Based Quadruple Regimen as First Line Therapy for Treating Helicobacter Pylori Infected Naïve Patients." Journal of Infection in Developing Countries 19, no. 6 (2025): 843. https://doi.org/10.3855/jidc.20505.
MLA (9th ed.) CitationAM, Hassan, et al. "Efficacy and Safety of Nitazoxanide Based Quadruple Regimen as First Line Therapy for Treating Helicobacter Pylori Infected Naïve Patients." Journal of Infection in Developing Countries, vol. 19, no. 6, 2025, p. 843, https://doi.org/10.3855/jidc.20505.